1. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
- Author
-
Holger Stein, Hans A. Kretzschmar, Michael Mäder, Markus Otto, Olaf Gefeller, Sigrid Poser, Thomas Weber, Inga Zerr, Monika Bodemer, and Annemarie Szudra
- Subjects
Adult ,Male ,medicine.medical_specialty ,Pathology ,Neurology ,Akinetic mutism ,Gastroenterology ,Creutzfeldt-Jakob Syndrome ,Central nervous system disease ,03 medical and health sciences ,0302 clinical medicine ,Cerebrospinal fluid ,Internal medicine ,mental disorders ,medicine ,Dementia ,Humans ,Prospective Studies ,Prospective cohort study ,030304 developmental biology ,Aged ,Aged, 80 and over ,0303 health sciences ,business.industry ,S100 Proteins ,Case-control study ,Middle Aged ,medicine.disease ,3. Good health ,ROC Curve ,Case-Control Studies ,Female ,Neurology (clinical) ,medicine.symptom ,business ,Myoclonus ,030217 neurology & neurosurgery - Abstract
We evaluated S-100 levels in paired cerebrospinal fluid (CSF) and serum samples in a group of 135 patients referred to the German Creutzfeldt-Jakob disease (CJD) surveillance unit from June 1993 to May 1995. The patients were seen in a prospective case control study. The diagnosis of probable CJD during life was made in any patient presenting with rapidly progressive dementia of less than 2 years' duration, typical periodic sharp wave complexes (PSWCs) in the EEG and at least two of the following findings: myoclonus, visual/or cerebellar symptoms, pyramidal and/or extrapyramidal signs and/or akinetic mutism. Patients presenting with the above clinical signs and symptoms but without PSWCs were classified as possible, while those with a dementia of a duration exceeding 2 years and without PSWCs were classified as other. S-100 was determined in paired CSF and serum samples by a commercially available enzyme-linked immunosorbent assay. In a group of 76 patients with definite and probable CJD, S-100 concentration (median 25 ng/ml, range 2-117) in CSF was significantly higher (P < 0.0001) than in 32 patients diagnosed as other (median 4 ng/ml, range 1-19). Serum levels of S-100 were below 0.5 ng/ml in all groups. At a cut-off of 8 ng/ml an optimum sensitivity of 84.2% with a specificity of 90.6% for the diagnosis of CJD by the determination of S-100 in CSF is obtained. S-100 levels exceeding 8 ng/ml in CSF support the diagnosis of CJD in any patient presenting with rapidly progressive dementia.
- Published
- 1997